KEVIN ERICKSON to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications KEVIN ERICKSON has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.657
-
The cost-effectiveness of lipid lowering for primary cardiovascular prevention in chronic kidney disease: moving beyond statins. Kidney Int. 2019 07; 96(1):22-25.
Score: 0.399
-
Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol. 2013 Mar 26; 61(12):1250-8.
Score: 0.258